JP2024527535A5 - - Google Patents
Info
- Publication number
- JP2024527535A5 JP2024527535A5 JP2023579728A JP2023579728A JP2024527535A5 JP 2024527535 A5 JP2024527535 A5 JP 2024527535A5 JP 2023579728 A JP2023579728 A JP 2023579728A JP 2023579728 A JP2023579728 A JP 2023579728A JP 2024527535 A5 JP2024527535 A5 JP 2024527535A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- ring
- substituted
- cycloalkyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2021-0090244 | 2021-07-09 | ||
| KR10-2021-0090239 | 2021-07-09 | ||
| KR20210090239 | 2021-07-09 | ||
| KR20210090244 | 2021-07-09 | ||
| KR10-2022-0031603 | 2022-03-14 | ||
| KR20220031603 | 2022-03-14 | ||
| PCT/KR2022/009980 WO2023282702A1 (ko) | 2021-07-09 | 2022-07-08 | Shp2 억제제 및 이의 용도 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024527535A JP2024527535A (ja) | 2024-07-25 |
| JP2024527535A5 true JP2024527535A5 (cg-RX-API-DMAC7.html) | 2025-07-15 |
| JP7843785B2 JP7843785B2 (ja) | 2026-04-10 |
Family
ID=84801788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579728A Active JP7843785B2 (ja) | 2021-07-09 | 2022-07-08 | Shp2阻害剤及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12029739B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4368625A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7843785B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102682323B1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022309195B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226206A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309984A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024000271A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202319056A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023282702A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023172940A1 (en) | 2022-03-08 | 2023-09-14 | Revolution Medicines, Inc. | Methods for treating immune refractory lung cancer |
| WO2023169170A1 (zh) * | 2022-03-10 | 2023-09-14 | 捷思英达控股有限公司 | 作为shp2抑制剂的杂环化合物、包括该杂环化合物的组合物、及其使用方法 |
| CN119768393A (zh) | 2022-05-25 | 2025-04-04 | 医肯纳肿瘤学公司 | Mek抑制剂和其用途 |
| EP4536364A1 (en) | 2022-06-10 | 2025-04-16 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2024125603A1 (zh) * | 2022-12-15 | 2024-06-20 | 江苏威凯尔医药科技有限公司 | Shp2抑制剂及其应用 |
| AU2024206693A1 (en) * | 2023-01-05 | 2025-06-26 | Kanaph Therapeutics Inc. | Shp2 inhibitor and uses thereof |
| CN121487738A (zh) | 2023-03-30 | 2026-02-06 | 锐新医药公司 | 诱导ras gtp水解的组合物和其用途 |
| CN121487951A (zh) | 2023-04-07 | 2026-02-06 | 锐新医药公司 | 大环ras抑制剂 |
| WO2024211712A1 (en) | 2023-04-07 | 2024-10-10 | Revolution Medicines, Inc. | Condensed macrocyclic compounds as ras inhibitors |
| AU2024251341A1 (en) | 2023-04-14 | 2025-10-16 | Revolution Medicines, Inc. | Crystalline forms of a ras inhibitor |
| EP4695261A1 (en) | 2023-04-14 | 2026-02-18 | Revolution Medicines, Inc. | Crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof |
| KR20260019479A (ko) | 2023-05-04 | 2026-02-10 | 레볼루션 메디슨즈, 인크. | Ras 관련 질환 또는 장애를 위한 병용 요법 |
| CN121889155A (zh) | 2023-08-07 | 2026-04-17 | 锐新医药公司 | 用于治疗ras蛋白相关疾病或病症的rmc-6291 |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025110772A1 (ko) * | 2023-11-22 | 2025-05-30 | 엘젠테라퓨틱스 주식회사 | 이미다졸로-피리딘 유도체 및 이의 용도 |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
| WO2026090116A2 (en) | 2024-10-21 | 2026-04-30 | Revolution Medicines, Inc. | Ras inhibitors |
| US20260108528A1 (en) | 2024-10-22 | 2026-04-23 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2026090245A1 (en) | 2024-10-22 | 2026-04-30 | Revolution Medicines, Inc. | Use of ras inhibitors for treating cancer |
| WO2026106912A1 (en) | 2024-11-12 | 2026-05-21 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026112260A1 (en) | 2024-11-21 | 2026-05-28 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026122764A2 (en) | 2024-12-06 | 2026-06-11 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026128688A2 (en) | 2024-12-13 | 2026-06-18 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026161839A1 (en) | 2025-01-27 | 2026-07-30 | Revolution Medicines, Inc. | Ras inhibitors |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004520299A (ja) | 2000-12-12 | 2004-07-08 | ニューロジェン・コーポレーション | スピロ[イソベンゾフラン−1,4’−ピペリジン]−3−オン類及び3h−スピロイソベンゾフラン−1,4’−ピペリジン類 |
| EP1583747A2 (en) | 2002-12-31 | 2005-10-12 | Vertex Pharmaceuticals Incorporated | Inhibitors of phosphatases |
| KR102218333B1 (ko) | 2016-06-07 | 2021-02-22 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| IL311645B2 (en) * | 2016-07-12 | 2025-11-01 | Revolution Medicines Inc | 2,5- disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines asallosteric shp2 inhibitors |
| SG11201908820VA (en) | 2017-03-23 | 2019-10-30 | Jacobio Pharmaceuticals Co Ltd | Novel heterocyclic derivatives useful as shp2 inhibitors |
| BR112020007058A2 (pt) | 2017-10-12 | 2020-10-06 | Revolution Medicines, Inc. | compostos de piridina, pirazina, e triazina como inibidores de shp2 alostéricos |
| CN117263942A (zh) | 2018-03-21 | 2023-12-22 | 传达治疗有限公司 | Shp2磷酸酶抑制剂及其使用方法 |
| RU2020133727A (ru) * | 2018-03-21 | 2022-04-21 | Сучжоу Пухе Биофарма Ко., Лтд. | Ингибиторы shp2 и их применение |
| EP3847744B1 (en) | 2018-09-07 | 2025-01-15 | Belimo Holding AG | An actuator with an electric motor and a method of controlling the electric motor to maintain a current position |
| JP7337174B2 (ja) * | 2018-09-18 | 2023-09-01 | ニカング セラピューティクス, インコーポレイテッド | Srcホモロジー-2ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体 |
| CN112839935A (zh) * | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| TW202028183A (zh) | 2018-10-10 | 2020-08-01 | 大陸商江蘇豪森藥業集團有限公司 | 含氮雜芳類衍生物調節劑、其製備方法和應用 |
| MA53921A (fr) | 2018-10-17 | 2022-01-26 | Array Biopharma Inc | Inhibiteurs de protéine tyrosine phosphatase |
| AU2020251841B2 (en) | 2019-04-02 | 2025-01-30 | Array Biopharma Inc. | Protein tyrosine phosphatase inhibitors |
| WO2021043077A1 (zh) | 2019-09-06 | 2021-03-11 | 四川科伦博泰生物医药股份有限公司 | 一种取代吡嗪化合物、其制备方法和用途 |
| CN110734480B (zh) | 2019-11-07 | 2021-08-24 | 中国科学院遗传与发育生物学研究所 | 大肠杆菌分子伴侣GroEL/ES在协助合成植物Rubisco中的应用 |
| WO2021115286A1 (zh) | 2019-12-10 | 2021-06-17 | 成都倍特药业股份有限公司 | 一种可用作shp2抑制剂的含氮杂原子的六元并五元芳环衍生物 |
| WO2021147879A1 (zh) | 2020-01-21 | 2021-07-29 | 贝达药业股份有限公司 | Shp2抑制剂及其应用 |
| TW202144334A (zh) | 2020-04-03 | 2021-12-01 | 大陸商上海翰森生物醫藥科技有限公司 | 含氮雜芳類衍生物游離鹼的晶型 |
| CN115362149B (zh) | 2020-04-26 | 2024-05-14 | 贝达药业股份有限公司 | Shp2抑制剂及其组合物和应用 |
| CN115279749B (zh) | 2020-04-30 | 2024-05-10 | 贝达药业股份有限公司 | Shp2抑制剂及其组合物和应用 |
| TW202214584A (zh) | 2020-07-24 | 2022-04-16 | 大陸商貝達藥業股份有限公司 | Shp2抑制劑及其組合物和應用 |
-
2022
- 2022-07-08 WO PCT/KR2022/009980 patent/WO2023282702A1/ko not_active Ceased
- 2022-07-08 EP EP22838054.9A patent/EP4368625A4/en active Pending
- 2022-07-08 CA CA3226206A patent/CA3226206A1/en active Pending
- 2022-07-08 TW TW111125765A patent/TW202319056A/zh unknown
- 2022-07-08 MX MX2024000271A patent/MX2024000271A/es unknown
- 2022-07-08 KR KR1020220084532A patent/KR102682323B1/ko active Active
- 2022-07-08 IL IL309984A patent/IL309984A/en unknown
- 2022-07-08 AU AU2022309195A patent/AU2022309195B2/en active Active
- 2022-07-08 JP JP2023579728A patent/JP7843785B2/ja active Active
-
2024
- 2024-01-08 US US18/407,400 patent/US12029739B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102142177B1 (ko) | Ezh2 억제용 하이드로클로라이드 염 형태 | |
| CN108290878B (zh) | 新的膜铁转运蛋白抑制剂 | |
| KR20250120376A (ko) | 축합환 화합물 및 이의 응용 | |
| JP4520533B2 (ja) | 縮合アミノジヒドロチアジン誘導体 | |
| KR101635227B1 (ko) | 벤젠 또는 티오펜 유도체 및 vap-1 억제제로서 이의 용도 | |
| KR20230070207A (ko) | 항바이러스제로서 작용화된 펩티드 | |
| CN105085429B (zh) | 芳杂环类衍生物及其在药物上的应用 | |
| JP7439018B2 (ja) | 置換アリールエーテル系化合物、その調製方法、医薬組成物およびその応用 | |
| CN107151250B (zh) | 嘧啶类七元环化合物、其制备方法、药用组合物及其应用 | |
| KR20220088375A (ko) | 피롤아미드 화합물 및 그 용도 | |
| TW202034910A (zh) | 非酒精性脂肪性肝病的治療 | |
| WO2024078592A1 (zh) | 靶向成纤维细胞活化蛋白的药物及其应用 | |
| CN119708105A (zh) | 甾体化合物及其应用 | |
| WO2023202642A1 (zh) | Rho相关蛋白激酶抑制剂及其制备和应用 | |
| KR20240124324A (ko) | 비스(아자니릴리덴)설포닐 구조를 함유하는 화합물 및 약제에서의 이의 용도 | |
| CN117580577A (zh) | 肾损伤的预防和/或治疗用医药组合物以及自噬活化剂 | |
| CN119708106A (zh) | 甾体化合物及其应用 | |
| CN119661618A (zh) | 甾体化合物及其应用 | |
| KR20200112810A (ko) | 헤테로아릴 아미드 화합물, 이에 대한 제조 방법, 이의 약학적 조성물 및 이의 적용 | |
| RU2024103122A (ru) | Ингибитор shp2 и его применение | |
| CN112979675A (zh) | 一种小分子含硫杂环化合物 | |
| JP2024540402A (ja) | 新規オーリスタチン類似体およびその免疫複合体 | |
| WO2023209368A1 (en) | Nitrogen comprising heterocyclic derivatives for the treatment of disorders associated with gpr55 receptor | |
| JP2025500404A (ja) | 新規オーリスタチン類似体およびその免疫複合体 | |
| WO2015179697A1 (en) | Compounds for the treatment of bacterial infections |